Safety Study of Intranasal Etripamil for the Termination of Spontaneous Episodes of Paroxysmal Supraventricular Tachycardia (PSVT). NODE-302
Clinical trial NCT03635996 · TERMINATED
Trial details
- NCT number
- NCT03635996
- Sponsor
- Milestone Pharmaceuticals Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-10
- Primary completion
- 2020-11-13
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.